A detailed history of Garde Capital, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Garde Capital, Inc. holds 5,956 shares of MRK stock, worth $677,137. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,956
Previous 6,089 2.18%
Holding current value
$677,137
Previous $803,000 8.22%
% of portfolio
0.05%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

SELL
$123.8 - $132.96 $16,465 - $17,683
-133 Reduced 2.18%
5,956 $737,000
Q1 2024

May 29, 2024

SELL
$113.24 - $131.95 $108,257 - $126,144
-956 Reduced 13.57%
6,089 $803,000
Q4 2023

Feb 21, 2024

BUY
$100.18 - $109.02 $143,057 - $155,680
1,428 Added 25.42%
7,045 $768,000
Q3 2023

Nov 17, 2023

BUY
$102.95 - $114.33 $6,177 - $6,859
60 Added 1.08%
5,617 $578,000
Q2 2023

Aug 28, 2023

BUY
$108.61 - $118.38 $422,927 - $460,971
3,894 Added 234.16%
5,557 $641,000
Q4 2022

Feb 24, 2023

BUY
$87.44 - $112.11 $14,427 - $18,498
165 Added 11.01%
1,663 $185,000
Q4 2021

Feb 25, 2022

BUY
$72.28 - $90.54 $108,275 - $135,628
1,498 New
1,498 $115,000
Q3 2021

Nov 17, 2021

SELL
$71.68 - $78.83 $111,534 - $122,659
-1,556 Closed
0 $0
Q2 2021

Aug 19, 2021

SELL
$70.31 - $77.77 $89,574 - $99,078
-1,274 Reduced 45.02%
1,556 $121,000
Q1 2021

May 24, 2021

SELL
$68.86 - $81.11 $58,048 - $68,375
-843 Reduced 22.95%
2,830 $218,000
Q4 2020

Feb 26, 2021

BUY
$71.77 - $79.65 $263,611 - $292,554
3,673 New
3,673 $300,000
Q1 2018

May 16, 2018

SELL
$50.96 - $59.23 $209,445 - $243,435
-4,110 Closed
0 $0
Q4 2017

Feb 23, 2018

SELL
$51.62 - $61.64 $8,001 - $9,554
-155 Reduced 3.63%
4,110 $231,000
Q3 2017

Nov 17, 2017

BUY
$58.67 - $63.13 $250,227 - $269,249
4,265
4,265 $273,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Garde Capital, Inc. Portfolio

Follow Garde Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Garde Capital, Inc. with notifications on news.